The future of the global bio-imaging market looks promising with opportunities in the clinic, diagnostic center, hospital, and laboratory markets. The global bio-imaging market is expected to reach an estimated $17.0 billion by 2030 with a CAGR of 15.7% from 2024 to 2030. The major drivers for this market are increasing demand of bio imaging instrument as an advancements in the imaging technologies, rising prevalence of chronic diseases and aging world population, and increasing number of diagnostic centers and radiopharmaceuticals.
Some of the key questions
answered in this exclusive report are:
Q.1. What are some of
the most promising, high-growth opportunities for the bio-imaging market by
type (elastography, magnetic resonance imaging, medical ultrasonography or
ultrasound, and X-ray radiography), technology (medical and molecular), end use
(clinics, diagnostic centers, hospitals, and laboratories), and region (North
America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will
grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and
why?
Q.4. What are the key
factors affecting market dynamics? What are the key challenges and business
risks in this market?
Q.5. What are the
business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market
and the reasons behind them?
Q.7. What are some of
the changing demands of customers in the market?
Q.8. What are the new
developments in the market? Which companies are leading these developments?
Q.9. Who are the major
players in this market? What strategic initiatives are key players pursuing for
business growth?
Q.10. What are some of
the competing products in this market and how big of a threat do they pose for
loss of market share by material or product substitution?
Q.11. What M&A
activity has occurred in the last 5 years and what has its impact been on the
industry?
Market Segmentation:
In this market,
elastography, magnetic resonance imaging, medical ultrasonography or
ultrasound, and X-ray radiography are the major segments of bio-imaging market
by type. Lucintel forecasts that X-ray radiography is expected to witness
highest growth over the forecast period due to its increasing adoption of
emergency medicine, orthopedics, and general radiology.
Within this market,
hospitals will remain the largest segment due to significantly growing
developed infrastructure and advanced imaging facilities that enables hospitals
to streamline their operations.
North America will
remain the largest region during the forecast period due to presence of
well-established healthcare systems, sophisticated medical facilities,
increasing incidence of cancer and cardic diseases, and high adoption of
healthcare insurance policies among the population particularly in the USA.
Bioclinica, Bracco
Imaging, Fonar, Bayer Healthcare Pharmaceuticals, Covidin, GE Healthcare, and
Gammamedica are the major suppliers in the bio-imaging market.
About
Lucintel
Lucintel, the premier global
management consulting and market research firm, creates winning strategies for
growth. It offers market assessments, competitive analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports
1. Pharmaceutical Contract Manufacturing Market
3. Stent Market
5. 3D Printing Medical
Device Market
8. Medical Lifting Sling
Market
9. Liquid Biopsy Market
No comments:
Post a Comment